SE9900431D0 - Monoklonal antikropp - Google Patents

Monoklonal antikropp

Info

Publication number
SE9900431D0
SE9900431D0 SE9900431A SE9900431A SE9900431D0 SE 9900431 D0 SE9900431 D0 SE 9900431D0 SE 9900431 A SE9900431 A SE 9900431A SE 9900431 A SE9900431 A SE 9900431A SE 9900431 D0 SE9900431 D0 SE 9900431D0
Authority
SE
Sweden
Prior art keywords
inhibitor
monoclonal antibody
activity
monitoring
systems involving
Prior art date
Application number
SE9900431A
Other languages
English (en)
Inventor
Johan Stenflo
Original Assignee
Johan Stenflo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johan Stenflo filed Critical Johan Stenflo
Priority to SE9900431A priority Critical patent/SE9900431D0/sv
Publication of SE9900431D0 publication Critical patent/SE9900431D0/sv
Priority to EP00906836A priority patent/EP1151013B1/en
Priority to AT00906836T priority patent/ATE361320T1/de
Priority to US09/890,949 priority patent/US6967082B1/en
Priority to AU28393/00A priority patent/AU2839300A/en
Priority to PCT/SE2000/000210 priority patent/WO2000047626A1/en
Priority to DE60034660T priority patent/DE60034660T2/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
SE9900431A 1999-02-09 1999-02-09 Monoklonal antikropp SE9900431D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9900431A SE9900431D0 (sv) 1999-02-09 1999-02-09 Monoklonal antikropp
EP00906836A EP1151013B1 (en) 1999-02-09 2000-02-03 Monoclonal antibody against protein c inhibitor
AT00906836T ATE361320T1 (de) 1999-02-09 2000-02-03 Monoklonaler antikörper gegen protein c inhibitor
US09/890,949 US6967082B1 (en) 1999-02-09 2000-02-03 Monoclonal antibody
AU28393/00A AU2839300A (en) 1999-02-09 2000-02-03 Monoclonal antibody
PCT/SE2000/000210 WO2000047626A1 (en) 1999-02-09 2000-02-03 Monoclonal antibody
DE60034660T DE60034660T2 (de) 1999-02-09 2000-02-03 Monoklonaler antikörper gegen protein c inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900431A SE9900431D0 (sv) 1999-02-09 1999-02-09 Monoklonal antikropp

Publications (1)

Publication Number Publication Date
SE9900431D0 true SE9900431D0 (sv) 1999-02-09

Family

ID=20414404

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9900431A SE9900431D0 (sv) 1999-02-09 1999-02-09 Monoklonal antikropp

Country Status (7)

Country Link
US (1) US6967082B1 (sv)
EP (1) EP1151013B1 (sv)
AT (1) ATE361320T1 (sv)
AU (1) AU2839300A (sv)
DE (1) DE60034660T2 (sv)
SE (1) SE9900431D0 (sv)
WO (1) WO2000047626A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200407335A (en) * 2002-07-22 2004-05-16 Chugai Pharmaceutical Co Ltd Non-neutralizing antibody to inhibit the inactivation of activated protein C
WO2004065418A1 (ja) * 2003-01-20 2004-08-05 Chugai Seiyaku Kabushiki Kaisha 抗pci中和抗体
WO2007035766A2 (en) * 2005-09-19 2007-03-29 The Johns Hopkins University Biomarker for prostate cancer
US9045716B2 (en) 2006-11-08 2015-06-02 Cp Kelco U.S., Inc. Surfactant thickened systems comprising microfibrous cellulose and methods of making same
WO2011038301A2 (en) 2009-09-25 2011-03-31 Xoma Technology Ltd. Screening methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2749619B2 (ja) 1989-03-10 1998-05-13 エーザイ株式会社 活性化ヒトプロテインｃとヒトプロテインｃインヒビターの複合体の測定方法および測定試薬
DK72593D0 (da) * 1993-06-18 1993-06-18 Symbicom Ab Rekombinant protein
JPH07238099A (ja) * 1994-02-25 1995-09-12 Dai Ichi Pure Chem Co Ltd モノクローナル抗体及びこれを用いる免疫学的測定法
US5856182A (en) 1996-11-18 1999-01-05 Beckman Coulter, Inc. Monoclonal antibodies specific for the PSA-ACT complex
JPH11124399A (ja) * 1997-10-21 1999-05-11 Eisai Co Ltd プロテインｃインヒビターとプロテアーゼの複合体測定用モノクローナル抗体

Also Published As

Publication number Publication date
DE60034660D1 (de) 2007-06-14
WO2000047626A1 (en) 2000-08-17
DE60034660T2 (de) 2007-12-27
EP1151013A1 (en) 2001-11-07
ATE361320T1 (de) 2007-05-15
EP1151013B1 (en) 2007-05-02
AU2839300A (en) 2000-08-29
US6967082B1 (en) 2005-11-22

Similar Documents

Publication Publication Date Title
Lima et al. Heparan sulfate modulates kinin release by Trypanosoma cruzi through the activity of cruzipain
Gearing et al. Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysin
NO923469L (no) Chymotrypsin-lignende proteaser og deres inhibitorer
EA199700087A1 (ru) Способ ингибирования катепсина к
TR200003036T2 (tr) 12,13-Modifiye edilmiş epotilon türevleri
DK1268847T3 (da) Ubiquitin-ligaseassay
HUP0303246A2 (hu) Aktív fehérjék fokozott kinyerése
Leonardi et al. Purification and characterisation of two hemorrhagic metalloproteinases from the venom of the long-nosed viper, Vipera ammodytes ammodytes
Smolka et al. Purification and partial characterization of a thrombin-like enzyme, balterobin, from the venom of Bothrops alternatus
ATE323759T1 (de) Rückgewinnung eines proteins bei hohem ph-wert
ATE292801T1 (de) Verfahren zum screening von inhibitoren von asp2
ATE226254T1 (de) Reagenz zur behandlung von arthritischen zustaenden
ATE315100T1 (de) Verfahren zur bestimmung der aktivität der faktor vii-aktivierenden protease aus proteinlösungen
PT1115745E (pt) Purificacao de fibrinogenio de fluidos por precipitacao e cromatografia de interaccao hidrofobica
SE9900431D0 (sv) Monoklonal antikropp
ATE219247T1 (de) Methoden zur feststellung von alzheimerscher krankheit
Kennett et al. Comparative histochemical, biochemical and immunocytochemical studies of cathepsin B in human gingival
ES2149448T3 (es) Agentes terapeuticos y analiticos.
Petrovan et al. Purification and characterization of multisquamase, the prothrombin activator present in Echis multisquamatus venom
DE60230147D1 (de) Verfahren zur überwachung und modulierung von proteinfaltung
ATE369748T1 (de) Verfahren zur käseherstellung
WO2001063293A3 (en) Diagnosis and treatment of schizophrenia
ATE288081T1 (de) Verfahren zum selektieren von inhibitoren für enzyme
ATE229339T1 (de) Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten
JP2003286300A (ja) 血液凝固第ｖｉｉ因子活性化プロテアーゼに対する抑制性モノクローナル抗体